Literature DB >> 12640054

Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

K Hamada1, M Hirayama, H Watanabe, R Kobayashi, H Ito, T Ieda, Y Koike, G Sobue.   

Abstract

OBJECTIVES: To elucidate the factors associated with severity of cardiac sympathetic nerve involvement in idiopathic Parkinson's disease (PD).
METHODS: (123)I-metaiodobenzylguanidine uptake was examined in 88 patients with PD. The ratio of the uptake in the heart (H) to that in the mediastinum (M) (the H/M ratio) was calculated and correlated with age at onset, age at examination, and disease severity and duration. Twenty five healthy people were also examined as a control.
RESULTS: There was a mild but significant negative correlation between H/M ratio and age at onset (early, r = -0.33, p = 0.002; delayed, r = -0.34, p = 0.001) and between Hoehn and Yahr (H-Y) stage (early, r = -0.30, p = 0.006; delayed, r = -0.32, p = 0.003). There was no significant correlation between disease duration and H/M ratio. When patients with PD were classified into four subgroups on the basis of age at onset (> 62 or < 62 years) and disease severity (H-Y > III or H-Y < or = II), the median H/M ratio of the older and more severe group was significantly lower than that of the younger and less severe group (p = 0.005).
CONCLUSION: This study suggests that late onset, high severity PD is associated with myocardial sympathetic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640054      PMCID: PMC1738357          DOI: 10.1136/jnnp.74.4.423

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.

Authors:  S Orimo; E Ozawa; T Oka; S Nakade; K Tsuchiya; M Yoshimoto; K Wakabayashi; H Takahashi
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

2.  Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30).

Authors:  H Watanabe; K Misu; M Hirayama; N Hattori; T Yoshihara; M Doyu; G Sobue
Journal:  J Neurol       Date:  2001-07       Impact factor: 4.849

3.  Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

Authors:  M S Stanton; M M Tuli; N L Radtke; J J Heger; W M Miles; B H Mock; R W Burt; H N Wellman; D P Zipes
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

4.  Orthostatic hypotension from sympathetic denervation in Parkinson's disease.

Authors:  D S Goldstein; C S Holmes; R Dendi; S R Bruce; S-T Li
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

5.  A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure.

Authors:  S Hakusui; T Yasuda; T Yanagi; J Tohyama; Y Hasegawa; Y Koike; M Hirayama; A Takahashi
Journal:  J Auton Nerv Syst       Date:  1994-09

6.  Parkinson's Disease Society Brain Bank, London: overview and research.

Authors:  S E Daniel; A J Lees
Journal:  J Neural Transm Suppl       Date:  1993

7.  Does ageing aggravate parkinsonian disability?

Authors:  J Blin; B Dubois; A M Bonnet; M Vidailhet; M Brandabur; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

8.  Combined effect of age and severity on the risk of dementia in Parkinson's disease.

Authors:  Gilberto Levy; Nicole Schupf; Ming-Xin Tang; Lucien J Cote; Elan D Louis; Helen Mejia; Yaakov Stern; Karen Marder
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

9.  Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

Authors:  D M Wieland; J Wu; L E Brown; T J Mangner; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057

10.  Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

View more
  15 in total

1.  Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy.

Authors:  N Mabuchi; M Hirayama; Y Koike; H Watanabe; H Ito; R Kobayashi; K Hamada; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

2.  2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.

Authors:  Ka Kit Wong; David M Raffel; Nicolaas I Bohnen; Gulcin Altinok; Sid Gilman; Kirk A Frey
Journal:  J Nucl Med       Date:  2016-08-18       Impact factor: 10.057

3.  Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Miki Ueda; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

4.  Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.

Authors:  Fumitada Yamashita; M Hirayama; T Nakamura; M Takamori; N Hori; K Uchida; T Hama; Gen Sobue
Journal:  Clin Auton Res       Date:  2010-02-03       Impact factor: 4.435

5.  Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.

Authors:  Ka Kit Wong; David M Raffel; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen; Sid Gilman
Journal:  Radiology       Date:  2012-07-27       Impact factor: 11.105

6.  Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.

Authors:  Kenji Ishibashi; Yuko Saito; Shigeo Murayama; Kazutomi Kanemaru; Keiichi Oda; Kiichi Ishiwata; Hidehiro Mizusawa; Kenji Ishii
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

7.  123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.

Authors:  Tomoyuki Miyamoto; Masayuki Miyamoto; Keisuke Suzuki; Momoka Nishibayashi; Masaoki Iwanami; Koichi Hirata
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

8.  Orthostatic hypotension as an early finding in Parkinson's disease.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435

9.  Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.

Authors:  Haruki Koike; Tomohiko Nakamura; Atsushi Hashizume; Ryoji Nishi; Shohei Ikeda; Yuichi Kawagashira; Masahiro Iijima; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2017-10-05       Impact factor: 4.849

10.  Pupillary supersensitivity and visual disturbance in Parkinson's disease.

Authors:  Norio Hori; Motoko Takamori; Masaaki Hirayama; Hirohisa Watanabe; Tomohiko Nakamura; Fumitada Yamashita; Hiroki Ito; Naoki Mabuchi; Gen Sobue
Journal:  Clin Auton Res       Date:  2008-02-11       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.